The Therapeutic Items Administration (TGA) has suggested of a present scarcity of Ryzodeg 70/30 FlexTouch insulin prefilled pens. The scarcity is predicted to proceed till mid-next yr.
To assist handle the scarcity, pharmacists may give individuals dwelling with diabetes Ryzodeg 70/30 Penfill cartridges as a substitute of Ryzodeg 70/30 FlexTouch prefilled pens beneath sure circumstances. Each merchandise include the identical drugs, on the identical power, have the identical storage necessities, and are administered by injection beneath the pores and skin (subcutaneous injection). Nonetheless, the gadget used to manage the drugs is totally different.
When you have been prescribed Ryzodeg 70/30 FlexTouch insulin prefilled pens, it’s vital to talk together with your pharmacist, physician, diabetes educator or nurse who can clarify to you the variations between FlexTouch prefilled pens and Penfill cartridges, how you can administer them, and supply you a brand new supply gadget (a NovoPen) at no cost.
The TGA web site supplies further details about the scarcity and steerage for customers of Ryzodeg 70/30 FlexTouch insulin prefilled pens.
